Current and Emerging Role of Chemotherapy in Oral Cancer
Study Trial design Sample size (HNSCC/oral cavity) Regimen RR/PFS/TTP/TTF/DOR OS Schornagel et al. (1995) [5] Phase III randomized trial for first-line chemotherapy treatment 131/43 (33 %) Edatrexate 70 mg/m2 weekly…
